Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic brinzolamide + timolol versus Azarga in open-angle glaucoma or ocular hypertension
2019-000921-39Phase 3Completed
- Sponsor
- Pharmathen
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of brinzolamide and timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Pharmathen. Primary endpoint: Primary efficacy endpoint. Started Feb 2019; status: completed.
02
Drugs
brinzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2019-000921-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000921-39.